Research Original Investigation Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome Invited Commentary The Wait for High-Sensitivity Troponin Is Over— Proceed Cautiously Frederick K. Korley, MD, PhD Since high-sensitivity troponin (hsTn) assays became avail- Furthermore, in the hsTnT era, there might be the temp- able for clinical use in Europe in 2010, clinicians in the United tation to base clinical decisions on initial hsTnT results. While States have been waiting eagerly for US Food and Drug Ad- this strategy may be safe for most patients, it may not be safe ministration (FDA) approval. It is finally here. High- for all patients. In the study cohort, the sensitivity of the ini- tial sample (at the 99th percentile upper reference level) was sensitivity troponin assays hold promise for earlier diag- 86% (95% CI, 79.7%-90.9%), and the negative predictive value Related article page 104 nosis of myocardial infarc- (NPV) was 98.2% (95% CI, 97.3%–98.9%). However, using the tion (MI), a decrease in the lower limit of quantitation of the assay (6 ng/L) as the decision- time required to rule out MI, a reduction in sex bias in the di- making cutoff, the NPV of the initial
JAMA Cardiology – American Medical Association
Published: Feb 13, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera